Anteris Technologies to Showcase Innovations at Key Events

Anteris Technologies to Present at Investor Conferences

AN Australian-based company, Anteris Technologies Global Corp. (AVR), which specializes in structural heart solutions, is gearing up for two significant healthcare investor conferences. Their Chief Executive Officer, Wayne Paterson, is scheduled to present at the 45th Annual TD Cowen Healthcare Conference and the Barclays 27th Annual Global Healthcare Conference. This marks a vital opportunity for Anteris to highlight their innovative DurAVR® Transcatheter Heart Valve (THV), a groundbreaking solution in cardiac care.

Conference Details for TD Cowen

The details for the TD Cowen Healthcare Conference are as follows:

Conference Overview

Date: March 5, 2025 (US time)
Format: Fireside chat with analyst, Joshua Jennings, and one-on-one meetings.
Time: 9:10-9:40 AM (US EST)
Room: Provincetown, 4th Floor
Location: Marriott Copley Plaza, Boston, MA.

Participation in Panel Discussion

In addition to the presentation, Anteris' Chief Medical Officer, Dr. Chris Meduri, will participate in a panel discussion dedicated to Structural Heart-TAVR, moderating the session alongside analyst Joshua Jennings.

Barclays Conference Insights

Following the TD Cowen event, Anteris will also engage at the Barclays Global Healthcare Conference:

Barclays Conference Details

Date: March 11, 2025 (US time)
Format: Fireside chat with analyst, Matt Miksic, and one-on-one meetings.
Time: 9:00-9:25 AM (US EST)
Room: Americana 3 (Track 3)
Location: Loews Miami Beach, Miami, FL.

Accessing the Webcasts

Both webcasts from the TD Cowen and Barclays events will be accessible through the Investor Center section on the Anteris website. This provides an opportunity for those unable to attend the live events to catch up on the latest advancements in Anteris' heart valve technology, including the DurAVR® THV.

About Anteris Technologies

Anteris Technologies Global Corp. is committed to enhancing heart health through innovative medical devices. Their pioneering product, the DurAVR® Transcatheter Heart Valve, is designed specifically for treating aortic stenosis and mimics a healthy aortic valve's function. With a foundation in Australia and a strong presence in Minneapolis, Anteris stands out as a leader in heart valve technology.

Technological Innovations

The DurAVR® THV is the first biomimetic valve of its kind, developed with input from leading interventional cardiologists and cardiac surgeons. Anteris leverages its patented ADAPT® tissue technology, recognized for its clinical safety and efficacy used in numerous patients worldwide. The system combines the valve and delivery technology, showing the potential for improving patient outcomes in heart surgeries.

Commitment to Advancements

As Anteris continues its dedication to developing advanced medical devices, it remains committed to growth and innovation, striving to enhance healthcare in cardiovascular treatment globally.

Frequently Asked Questions

What is Anteris Technologies known for?

Anteris Technologies specializes in structural heart solutions, developing innovative cardiac devices, including the DurAVR® THV.

When and where are the upcoming conferences?

The upcoming conferences are on March 5, 2025, at TD Cowen in Boston, MA, and March 11, 2025, at Barclays in Miami, FL.

How can I access the conference webcasts?

The webcasts can be accessed via the Investor Center on the Anteris website for those who cannot attend in person.

What technology does Anteris use in its heart valves?

Anteris uses ADAPT® tissue technology in its heart valves, which offers a biocompatible and durable solution for valve replacement.

What is the DurAVR® Transcatheter Heart Valve?

The DurAVR® THV is a biomimetic heart valve designed to treat aortic stenosis, mimicking the natural function of a healthy aortic valve.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.